Takeda Pharmaceutical (TAK) Net Cash Flow (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Net Cash Flow of -$881.0 million for Q2 2026, down 290.21% year-over-year from $463.2 million in Q2 2025, and down 223.83% quarter-over-quarter from $711.5 million in Q1 2026.
Takeda Pharmaceutical (TAK) Net Cash Flow (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Net Cash Flow history runs 9 years deep, the most recent figure standing at -$881.0 million for Q2 2026.
- In Q2 2026, Net Cash Flow fell 290.21% year-over-year to -$881.0 million; the TTM figure through Jun 2026 stood at $1.7 billion (up 160.0% YoY), while the FY2026 annual figure was $2.3 billion, up 674.5% from the prior year.
- Net Cash Flow for Q2 2026 stood at -$881.0 million, down from $711.5 million in the prior quarter.
- The five-year high for Net Cash Flow was $2.2 billion in Q3 2025, with the low at -$2.6 billion in Q4 2024.
- The 5-year median for Net Cash Flow is -$202.8 million (2023), against an average of -$83.1 million.
- Peak annual rise in Net Cash Flow reached 4081.95% in 2024, while the deepest fall reached 1318.55% in 2024.
- Takeda Pharmaceutical's Net Cash Flow stood at -$732.0 million in 2022, then surged by 75.44% to -$179.8 million in 2023, then plunged by 1318.55% to -$2.6 billion in 2024, then soared by 87.52% to -$318.4 million in 2025, then tumbled by 176.75% to -$881.0 million in 2026.
- Business Quant data shows TAK's Net Cash Flow at -$881.0 million in Q2 2026, $711.5 million in Q1 2026, and -$318.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -881.03 Mn |
| Jun 30, 2026 | -881.03 Mn |
| Mar 31, 2026 | 711.50 Mn |
| Mar 31, 2026 | 711.50 Mn |
| Dec 31, 2025 | -318.35 Mn |
| Dec 31, 2025 | -318.35 Mn |
| Sep 30, 2025 | 2.16 Bn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | -225.79 Mn |
| Jun 30, 2025 | -225.79 Mn |
| Mar 31, 2025 | -650.96 Mn |
| Mar 31, 2025 | -650.96 Mn |
| Dec 31, 2024 | -2.55 Bn |
| Dec 31, 2024 | -2.55 Bn |
| Sep 30, 2024 | 642.17 Mn |
| Sep 30, 2024 | 642.17 Mn |
| Jun 30, 2024 | 2.12 Bn |
| Jun 30, 2024 | 2.12 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.07 Bn |